Online Course
24
Nov
2023
2023
25
Nov
2023
2023
Molecular Diagnostics, Genomics in Cancer Online Course 2023
Chairs
Matti Aapro, CH – Joseph Gligorov, FR – Frederique Penault-Llorca, FR
Date
Friday 24 and Saturday 25 November 2023
Background
Following the success of the course "Molecular Diagnostics, Genomics in Breast Cancer 2021", which had more than 2200 registrations and 700 participants connected live from more than 100 countries, SPCC is pleased to propose a second edition in 2023 focusing on:
• Breast Cancer: pathology, molecular and multigene testing, clinical decision making with tests and clinical case discussion
• Other Cancers: markers for tailored treatment and clinical discussion on applicability and guidance from experts with live audience discussion
Learning Objectives
• Improving care for patients with breast and other cancers
• Discussing recent updates in molecular diagnostics in breast and other cancers
• Discussing recent updates in molecular diagnostics in breast and other cancers
• Practicing thanks to case discussions with experts
Target Group
Geneticists - Pathologists - Clinical Oncologists - Medical Oncologists - Haemato-Oncologists - Surgeons - Nurses - Patient Advocates – Radiologists – Epidemiologists - Molecular Biologists
Course Format
The course, consisting of 2 consecutive days of live sessions, will be held online with the participation of world-renowned experts.
It will be free of charge and can be accessed by registering on SPCC's OncoCorner e-learning platform. The material will remain available on-demand.
Continuing Medical Education accreditation
Application for CME accreditation has been submitted to the Accreditation Council of Oncology in Europe (ACOE).
The programme was recognised as being of high quality from both a scientific and didactic point of view and was awarded 5 CME credits.
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.
Acknowledgements
Sharing Progress in Cancer Care wishes to express its appreciation to Exact Sciences, Novartis and Veracyte for their support with unconditional educational grants.
Supporters have no input into speakers, the agenda or content for the programme.
Supporters have no input into speakers, the agenda or content for the programme.
24/11/2023 15:00 CET
DAY 1 - Breast and gynaecological cancer
24/11/2023 15:00 CET
Welcome and introduction
Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frederique Penault-Llorca, FR
24/11/2023 15:05 CET
How much information can we gain from classical pathology?
Expert: Roberto Salgado, BE
24/11/2023 15:25 CET
Molecular and multigene testing in early breast cancer – where do we stand?
Expert: Frederique Penault-Llorca, FR
24/11/2023 15:45 CET
Molecular gynaecological pathway: ovarian carcinoma with HRD, endometrial carcinoma with MSI HER2, and PD-L1 cervical carcinoma
Expert: Xavier Matias-Guiu Guia, ES
24/11/2023 16:05 CET
Clinical decision-making assisted by molecular/multigene testing in early breast cancer
Expert: Nadia Harbeck, DE
24/11/2023 16:25 CET
Educational sessions discussion and Q&A
Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frederique Penault-Llorca, FR
Expert: Xavier Matias-Guiu Guia, ES
Expert: Roberto Salgado, BE
24/11/2023 16:50 CET
Groups Session: Patient Cases discussion on Early Breast Cancer
Case 1: woman 29 years old
Case 2: woman 73 years old
Case 3: woman 45 years old
Case 4: woman 55 years old
Case 2: woman 73 years old
Case 3: woman 45 years old
Case 4: woman 55 years old
Expert: Sana Al Sukhun, JO
Expert: Maria-João Cardoso, PT
Expert: Nagi S. El Saghir, LB
Expert: Orit Kaidar-Person, IL
Expert: Melanie Machiels, BE
Expert: Giancarlo Pruneri, IT
Expert: Isabel T. Rubio, ES
Expert: Roberto Salgado, BE
Moderator: Joseph Gligorov, FR
Moderator: Nadia Harbeck, DE
25/11/2023 15:00 CET
DAY 2 - Other cancers
25/11/2023 15:00 CET
Welcome and introduction
Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frederique Penault-Llorca, FR
25/11/2023 15:05 CET
Thyroid Cancer; what to ask for in order to give the appropriate treatment (if available)
Expert: Aleš Ryška, CZ
25/11/2023 15:25 CET
Educational session discussion and Q&A
Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frederique Penault-Llorca, FR
Expert: Aleš Ryška, CZ
25/11/2023 15:45 CET
Lung Cancer; what to ask for in order to give the appropriate treatment (if available)
Expert: Fernando Lopez-Rios, ES
25/11/2023 16:05 CET
Educational session discussion and Q&A
Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frederique Penault-Llorca, FR
Discussant: Vanita Noronha, IN
Discussant: Christian Rolfo, US
Expert: Fernando Lopez-Rios, ES
25/11/2023 16:25 CET
Colorectal Cancer; what to ask for in order to give the appropriate treatment (if available)
Expert: Magali Svrcek, FR
25/11/2023 16:45 CET
Educational session discussion and Q&A
Chair: Matti Aapro, CH
Chair: Joseph Gligorov, FR
Chair: Frederique Penault-Llorca, FR
Discussant: Eric Van Cutsem, BE
Expert: Magali Svrcek, FR
25/11/2023 17:05 CET
Closure
![](https://attachment.oncocorner.net/48/2020052804045927.jpeg)
Matti Aapro
Sharing Progress in Cancer Care and Clinique de Genolier, Bellinzona and Genolier, Switzerland
![](https://attachment.oncocorner.net/48/2021071511101367.jpg)
Sana Al Sukhun
Al Hyatt Oncology Practice, Amman, Jordan
![](https://attachment.oncocorner.net/48/2024011801122489.jpg)
Maria-João Cardoso
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal
![](https://attachment.oncocorner.net/48/2024012609113527.jpg)
Nagi S. El Saghir
American University of Beirut Medical Center, Beirut, Lebanon
![](https://attachment.oncocorner.net/48/288.jpg)
Joseph Gligorov
Hospital Tenon Ap-Hp, Paris, France
![](https://attachment.oncocorner.net/48/2020072510123242.jpg)
Nadia Harbeck
Breast Center, LMU University Hospital, Munich, Germany
Orit Kaidar-Person
Sheba Medical Center, Ramat Gan, Israel
![](https://attachment.oncocorner.net/48/2023092709595357.png)
Fernando Lopez-Rios
Department of Pathology at "12 de Octubre" University Hospital, Madrid, Spain
![](https://attachment.oncocorner.net/48/2023053009474534.jpg)
Melanie Machiels
Radiation Oncologist at Iridium Netwerk, University of Antwerp, Wilrijk, Belgium
![](https://attachment.oncocorner.net/48/2023042611301306.jpg)
Xavier Matias-Guiu Guia
University of Barcelona, Barcelona, Spain
![](https://attachment.oncocorner.net/48/2023092012180369.jpeg)
Vanita Noronha
Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India
![](https://attachment.oncocorner.net/48/2021030912024026.jpg)
Frederique Penault-Llorca
Jean Perrin Center, Clermont-Ferrand, France
Giancarlo Pruneri
IRCCS National Cancer Institute, Milan, Italy
![](https://attachment.oncocorner.net/48/2023011012000985.jpg)
Christian Rolfo
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, USA
![](https://attachment.oncocorner.net/48/2021050609192590.jpg)
Isabel T. Rubio
Breast Surgical Unit, Clínica Universidad de Navarra, Madrid, Spain
![](https://attachment.oncocorner.net/48/2023042612221713.jpg)
Aleš Ryška
Charles University Medical Faculty Hospital, Hradec Kralove, Czech Republic
![](https://attachment.oncocorner.net/48/2023042611185889.jpg)
Roberto Salgado
GZA Hospitals, Antwerp, Belgium
Magali Svrcek
Sorbonne University, Paris, France
![](https://attachment.oncocorner.net/48/2021033008292359.jpg)
Eric Van Cutsem
University of Leuven, Leuven, Belgium
BREAST CANCER
COLON / RECTAL / COLORECTAL CANCER
GENERAL INTEREST
GYNAECOLOGICAL CANCERS
LUNG CANCER
PATHOLOGY
THYROID CANCER